We are grateful to our Board, Foundation and Committees for their commitment to steering the Institute to continued success.
Dr Robert (Bob) Edgar BEcon (Hons), PhD (Ohio State), FAICD
Appointed: April 2009
Dr Edgar has extensive experience in financial services, including 25 years at ANZ Bank where he retired as Deputy Chief Executive Officer in 2009. He is also a director on the boards of Djerriwarrh Securities, Linfox Armaguard Pty Ltd and Transurban Ltd.
Professor Warwick Anderson AM BS (Hons) UNE, PhD (Adelaide), DUniv (Adelaide), FAHA (Int), FRCPA (Hon), FAAHMS, DH (Newcastle)
Appointed: July 2015
Prof Anderson is the Secretary-General of the Human Frontier Science Program, which funds international cooperation in research into the complex mechanisms of living organisms. He was previously CEO of the National Health and Medical Research Council of and has been a member of numerous international medical research bodies. Professor Anderson is a Vice-Chancellor’s Professorial Fellow at Monash University and has previously held academic and research positions at Monash University, Baker Medical Research Institute, University of Sydney and Harvard Medical School. He was made a Member of the Order of Australia in 2005. Prof Anderson’s research focuses on the renal causes of hypertension, including humoural, neural and vascular remodelling aspects, resulting in 170 peer-reviewed articles. He was made a Member of the Order of Australia in 2005.
Mr Nigel Garrard BEcomm, AICD, CA FAMI
Appointed: March 2016
Mr Garrard has been the Managing Director and CEO of Orora Limited since 2013 when it was listed on the Australian Stock Exchange. Since starting his career at KPMG, Mr Garrard has held a number of senior executive postings including the Managing Director of SPC Ardmona, Coca Cola Amatil’s food and service division, Chiquita Brands South Pacific Ltd, and Amcor Australasia and Packaging Distribution. He is the former Chairperson of the Australian Government’s National Food Industry Strategy Ltd and has been a director of a number of industry and not-for-profit organisations. Mr Garrard is a director of the Packaging Council of Australia.
Special responsibilities: Chair, Hudson Foundation; Investment Committee member
Mr Andrew Leyden BComm
Appointed: March 2016
Mr Leyden has been a Managing Director of Lazard Corporate Advisory and its predecessors since 2003. He has also worked for Credit Suisse Group, ANZ McCaughan Dyson and Arthur Andersen.
Special responsibilities: Chair, Investment Committee; Hudson Foundation member
Professor Christina Mitchell MBBS, PhD, FRACP
Appointed: September 2011
Prof Mitchell is the Academic Vice-President and Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University. Prof Mitchell trained as a physician-scientist specialising in clinical haematology. In September 2011, she was promoted to the position of Dean. She was the first woman to be appointed Dean of Medicine in any of the group of eight universities in Australia. In March 2015, Prof Mitchell was inducted into the Victorian Honour Roll of Women for her leadership as the Dean. In April 2015, she received the Lemberg Medal which is awarded annually to a distinguished biochemist in Australia. She is also a member of the Australian Academy of Health and Medical Sciences.
Ms Zita Peach BSc, GAICD, FAMI
Appointed: May 2016
Ms Peach has been the Principal of Zita Peach Business Development Services since 2015. She has also worked in senior leadership roles as Executive Vice-President and Managing Director of Fresenius Kabi, Vice-President of Business Development at CSL Limited and Commercial Director at Merck Sharp Dohme. Ms Peach has extensive experience in commercialising technologies, licensing, mergers and acquisitions. Ms Peach is a graduate of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute. She is a director of Starpharma Holdings, Vision Eye Institute Limited, AirXpanders Inc, Monash IVF, Bionic Vision Technologies and Mt Buller, Mt Stirling Alpine Resorts Management Board.
Special responsibilities: Chair, Intellectual Property and Commercialisation Committee
Mr Graeme Wise
B.Ec (Monash), FAICD
Appointed: November 2013
Mr Wise began his career in sales and marketing, including 15 years at Alcoa, based in both Australia and the United Kingdom. In 1981, he moved to retailing with Myer before founding Adidem Pty Ltd to build and operate the Australian branch of The Body Shop chain of retail stores. Mr Wise is now Chair of the Adidem Group, which comprises companies in property, publishing and water purification. Mr Wise is also involved in philanthropic activities as founder and patron of The Big Issue magazine and Chair of the Wise Foundation.
Ms Maria Trinci
Appointed: March 2015
Ms Trinci has worked with KPMG, specialising in financial services since 2000, and was admitted to the partnership in 2012. Ms Trinci is currently the engagement partner for ANZ. She has worked in the banking industry in London, Edinburgh, Glasgow and New York with clients including Mellon, Deutsche Bank and Citigroup. Ms Trinci is also a volunteer board member and pro bono audit provider. She is Deputy Chair of the Cancer Council Victoria board and chairs their Finance, Risk and Audit Committee. She is involved in a variety of community service groups including the Ovarian Cancer Research Foundation, Crime Stoppers, Gay and Lesbian Switchboard Victoria and the Committee for Melbourne – Future Focus Group.
Special responsibilities: Chair, Finance and Audit Committee
Professor Erwin Loh
Appointed: May 2016
MBBS, LLB(Hons), MBA, MHSM, PhD, FAIM, FCMI, FAICD, FACLM, FCHSM, FRACMA
Prof Loh is Chief Medical Officer and Executive Director of Innovation, Patient Safety and Experience at Monash Health, Victoria’s largest health service. Prior to this he was the Deputy Chief Medical Officer at the Peter MacCallum Cancer Centre. He is a barrister and solicitor of the Supreme Court of Victoria and High Court of Australia. Prof Loh has a medical degree from the University of Melbourne and a law degree with honours from Monash University. He also has a Master of Business Administration, Master of Health Service Management and a PhD which examined doctors in senior hospital management. He is fellow of the Royal Australasian College of Medical Administrators, Australasian College of Health Service Management, Australian Institute of Company Directors and Australasian College of Legal Medicine.
Prof Loh is also on the board of the Monash Health Research Precinct and the Australasian College of Legal Medicine (where he is also Vice-President). He has previously been on the board of the Australian Medical Association (Victoria), the Law Institute of Victoria and the Royal Australasian College of Medical Administrators. He is an adjunct Clinical Professor at Monash University where he teaches health law and health services management. He is the chair of the Victorian State Committee of the Royal Australasian College of Administrators. Prof Loh has spoken at local and international conferences, published articles and book chapters on health law and medical management, and supervises doctoral students.
Mr Rob Merriel
Appointed: May 2014
BA, Grad Dip (Psych), Grad Dip (Accounting), CPA
Mr Merriel is a Certified Practicing Accountant with more than 35 years’ experience working in medical research (Baker IDI and Hudson Institute), healthcare (Melbourne Health and Southern Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). The current Chief Financial Officer and Chief Commercialisation Officer of Hudson Institute, Mr Merriel is a Director of MHRP Pty Ltd and was previously the director and company secretary of several biotechnology-focused companies, including BioGrid Australia, Biocomm, the Australian Technology Fund and Evivar.
Finance and Audit Committee
This committee assists the board in internal control and compliance, accounting and financial reporting and risk management processes of Hudson Institute.
Members: Ms Maria Trinci (Chair since 2015), Ms Carmel Mortell and Secretary Mr Rob Merriel. Hudson Institute’s CEO, Professor Bryan Williams, attends meetings of this board committee.
This committee advises the board and director on the effectiveness of investment policies, and approves the engagement of investment managers and investment transactions.
Members: Mr Andrew Leyden (Chair since November 2016), Mr Nigel Garrard (since November 2016), and Secretary Mr Rob Merriel. Hudson Institute’s Financial Accountant, Mrs Jessie Wo, attends meetings of this board committee.
Intellectual Property and Commercialisation Committee
This committee advises the board and director on statutory requirements for corporate governance and commercialisation of Hudson Institute’s intellectual property and related issues.